Trials / Terminated
TerminatedNCT03897530
Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers
Flavored Tobacco Product Regulation: Behavioral Economic Demand, Visual Attention, and Flavored Tobacco Product Availability
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This trial uses an Experimental Tobacco Marketplace to study the purchase of tobacco products in menthol cigarette smokers. Determining the level of substitutability of both flavored and unflavored/tobacco flavored e-cigarettes when menthol cigarettes are available and unavailable can help determine if a flavor ban (of either menthol cigarettes and/or flavored e-cigarettes) will lead to smoking cessation and/or harm reduction. A greater understanding of tobacco product purchasing could help inform possible regulatory actions by the Food and Drug Administration.
Detailed description
Participants view and purchase hypothetical tobacco products during four distinctly different Experimental Tobacco Marketplace (ETM) conditions. During the session, participants are presented with these randomly ordered conditions: menthol cigarettes and five flavored e-cigarettes (menthol/mint, fruits, sweets, alcohol, snacks/meals), menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes, non-menthol cigarettes and five flavored e-cigarettes, and non-menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes. Participants' visual attention is evaluated by eye-tracking equipment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Smoking Cessation Intervention | View and purchase hypothetical tobacco products during four distinctly different ETM |
| OTHER | Functional Assessment | Visual attention is evaluated via eye-tracking equipment |
| OTHER | Questionnaire Administration | Ancillary studies |
Timeline
- Start date
- 2019-06-30
- Primary completion
- 2023-07-20
- Completion
- 2023-07-20
- First posted
- 2019-04-01
- Last updated
- 2024-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03897530. Inclusion in this directory is not an endorsement.